• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体外使用苏拉明处理的人前列腺增生细胞的生长、形态及形态测定

Growth, morphology, and morphometry of human hypertrophic prostate cells treated with suramin in vitro.

作者信息

De Angeli S, Fandella A, Conconi M T, Anselmo G, Parnigotto P P

机构信息

Laboratory of Cellular Cultures, Regional Hospital USSL, Treviso, Italy.

出版信息

Prostate. 1994 Sep;25(3):117-24. doi: 10.1002/pros.2990250302.

DOI:10.1002/pros.2990250302
PMID:7520575
Abstract

This work studies the effects of suramin on the growth and morphology of cell strain U285, obtained from human prostate hypertrophic tissue and cultured in vitro. The FRAME cytotoxicity test was performed to evaluate the inhibition of growth induced by suramin. Cells were exposed to suramin at the time of seeding and 24 hours later; neutral red was added with and without suramin. An optical microscope connected to a computer-aided system and a scanning electron microscope were used to study morphological changes induced by suramin. Growth inhibition depends on drug concentration and exposure period. Moreover, the effect of suramin on neutral red uptake is reversible. Suramin 1,000 microM causes the cells to become spheroid, and they fail to form a monolayer. Our data indicate that the addition of suramin during the lag phase decreases the rate of cell proliferation.

摘要

本研究探讨了苏拉明对源自人前列腺增生组织并在体外培养的U285细胞株生长和形态的影响。进行FRAME细胞毒性试验以评估苏拉明诱导的生长抑制作用。在接种时和24小时后将细胞暴露于苏拉明;在有和没有苏拉明的情况下加入中性红。使用连接到计算机辅助系统的光学显微镜和扫描电子显微镜研究苏拉明诱导的形态变化。生长抑制取决于药物浓度和暴露时间。此外,苏拉明对中性红摄取的影响是可逆的。1000微摩尔的苏拉明会使细胞变成球形,并且它们无法形成单层。我们的数据表明,在延迟期添加苏拉明会降低细胞增殖速率。

相似文献

1
Growth, morphology, and morphometry of human hypertrophic prostate cells treated with suramin in vitro.体外使用苏拉明处理的人前列腺增生细胞的生长、形态及形态测定
Prostate. 1994 Sep;25(3):117-24. doi: 10.1002/pros.2990250302.
2
Production of epidermal growth factor in human prostatic cells cultured in vitro.体外培养的人前列腺细胞中表皮生长因子的产生。
Ann Anat. 2000 May;182(3):249-58. doi: 10.1016/S0940-9602(00)80030-8.
3
Effects of DHT and EGF on human hyperplastic prostate cells cultured in vitro: growth, morphology and phenotype characterisation.
Ann Anat. 1997 Jun;179(3):255-64. doi: 10.1016/s0940-9602(97)80111-2.
4
Effects of suramin on the proliferation of primary epithelial cell cultures derived from normal, benign hyperplastic and cancerous human prostates.苏拉明对源自正常、良性增生和癌性人类前列腺的原代上皮细胞培养物增殖的影响。
Prostate. 1993;22(1):75-89. doi: 10.1002/pros.2990220110.
5
Cytostatic effects of suramin on prostate cancer cells cultured from primary tumors.苏拉明对原发性肿瘤培养的前列腺癌细胞的细胞生长抑制作用。
J Urol. 1991 Mar;145(3):624-30. doi: 10.1016/s0022-5347(17)38408-2.
6
Influence of suramin alone or in combination with DHT and PDGF on the cell proliferation of benign and malignant human prostatic tissues in organ cultures.单独使用苏拉明或联合双氢睾酮(DHT)和血小板衍生生长因子(PDGF)对器官培养的人良性和恶性前列腺组织细胞增殖的影响。
Anticancer Res. 1991 Nov-Dec;11(6):2075-8.
7
Effect of suramin on the mitogenic response of the human prostate carcinoma cell line PC-3.苏拉明对人前列腺癌细胞系PC-3有丝分裂反应的影响。
Cancer. 1993 Feb 1;71(3 Suppl):1151-8. doi: 10.1002/1097-0142(19930201)71:3+<1151::aid-cncr2820711438>3.0.co;2-k.
8
Disruption of cellular energy balance by suramin in intact human prostatic carcinoma cells, a likely antiproliferative mechanism.苏拉明对完整人前列腺癌细胞能量平衡的破坏,一种可能的抗增殖机制。
Cancer Res. 1991 Dec 15;51(24):6629-35.
9
The inhibitory effect of suramin on telomerase activity and spheroid growth of C6 glioma cells.苏拉明对C6胶质瘤细胞端粒酶活性及球体生长的抑制作用。
Med Sci Monit. 2008 Aug;14(8):BR165-73.
10
[The enhancement of the chemotherapeutic effects on human prostate cancer cell--the combination with the growth factor interaction inhibitor (suramin)].[增强对人前列腺癌细胞的化疗效果——与生长因子相互作用抑制剂(苏拉明)联合使用]
Hinyokika Kiyo. 1993 Dec;39(12):1215-20.